Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1285295rdf:typepubmed:Citationlld:pubmed
pubmed-article:1285295lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:1285295lifeskim:mentionsumls-concept:C0025677lld:lifeskim
pubmed-article:1285295lifeskim:mentionsumls-concept:C0039902lld:lifeskim
pubmed-article:1285295lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1285295lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:1285295lifeskim:mentionsumls-concept:C0332324lld:lifeskim
pubmed-article:1285295pubmed:issue2-3lld:pubmed
pubmed-article:1285295pubmed:dateCreated1994-3-4lld:pubmed
pubmed-article:1285295pubmed:abstractTextIsothermal microcalorimetry was used in order to continuously monitor and quantitatively assess the action of two antineoplastic drugs, methotrexate (MTX) and 6-thioguanine (6-TG), on a human T-lymphoma cell line, CCRF-CEM. The results with MTX were compared with data from experiments with a MTX-resistant subline, CEM/MTX. The slope of the power-time curve after drug injection relative to that obtained during unperturbed growth, was used to construct dose-response curves. The normal cell line was characterized by a D50 value (i.e., the dose producing half the maximal response) of 0.05 microM for MTX and 0.38 microM for 6-TG. For the MTX-resistant subline the D50 value was 8 microM of MTX. Comparisons of the continuous power-time curves showed the inhibitory effect of 6-TG to be faster than that of MTX.lld:pubmed
pubmed-article:1285295pubmed:languageenglld:pubmed
pubmed-article:1285295pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1285295pubmed:citationSubsetIMlld:pubmed
pubmed-article:1285295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1285295pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1285295pubmed:statusMEDLINElld:pubmed
pubmed-article:1285295pubmed:issn0163-4992lld:pubmed
pubmed-article:1285295pubmed:authorpubmed-author:SchönAAlld:pubmed
pubmed-article:1285295pubmed:authorpubmed-author:BermudezJJlld:pubmed
pubmed-article:1285295pubmed:authorpubmed-author:BäckmanPPlld:pubmed
pubmed-article:1285295pubmed:issnTypePrintlld:pubmed
pubmed-article:1285295pubmed:volume20lld:pubmed
pubmed-article:1285295pubmed:ownerNLMlld:pubmed
pubmed-article:1285295pubmed:authorsCompleteYlld:pubmed
pubmed-article:1285295pubmed:pagination111-23lld:pubmed
pubmed-article:1285295pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1285295pubmed:meshHeadingpubmed-meshheading:1285295-...lld:pubmed
pubmed-article:1285295pubmed:meshHeadingpubmed-meshheading:1285295-...lld:pubmed
pubmed-article:1285295pubmed:meshHeadingpubmed-meshheading:1285295-...lld:pubmed
pubmed-article:1285295pubmed:meshHeadingpubmed-meshheading:1285295-...lld:pubmed
pubmed-article:1285295pubmed:meshHeadingpubmed-meshheading:1285295-...lld:pubmed
pubmed-article:1285295pubmed:meshHeadingpubmed-meshheading:1285295-...lld:pubmed
pubmed-article:1285295pubmed:meshHeadingpubmed-meshheading:1285295-...lld:pubmed
pubmed-article:1285295pubmed:meshHeadingpubmed-meshheading:1285295-...lld:pubmed
pubmed-article:1285295pubmed:meshHeadingpubmed-meshheading:1285295-...lld:pubmed
pubmed-article:1285295pubmed:meshHeadingpubmed-meshheading:1285295-...lld:pubmed
pubmed-article:1285295pubmed:meshHeadingpubmed-meshheading:1285295-...lld:pubmed
pubmed-article:1285295pubmed:articleTitleMicrocalorimetric evaluation of the effects of methotrexate and 6-thioguanine on sensitive T-lymphoma cells and on a methotrexate-resistant subline.lld:pubmed
pubmed-article:1285295pubmed:affiliationFacultat d'Odontologia, Universitat de Barcelona, Feixa Llarga, Spain.lld:pubmed
pubmed-article:1285295pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1285295pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1285295pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed